The SNCA is the effect gene that associated with the Parkinson's disease, and a previous report has indicated that the expression of the SNCA is controlled by the ZSCAN21.[32] Consistent with this indication, we have found a ZSCAN21 binding site in the transcription start site (TSS) region of the SNCA. The gene discussed is ZSCAN21; the disease is Parkinson disease.